Cargando…
Successful treatment of refractory IgA vasculitis with tofacitinib
Autores principales: | Xu, Yi-Fei, Li, Zi-Qi, Yang, Wan-Shan, Shi, Xiao-Wei, Han, Guang-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664339/ https://www.ncbi.nlm.nih.gov/pubmed/36386052 http://dx.doi.org/10.1016/j.jdcr.2022.09.030 |
Ejemplares similares
-
IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis
por: Itoh, Izumi, et al.
Publicado: (2019) -
Treatment of refractory IgA vasculitis with dapsone: a systematic review
por: Lee, Keum Hwa, et al.
Publicado: (2019) -
IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021) -
IgA vasculitis in children
por: Penido, Maria Goretti Moreira Guimarães, et al.
Publicado: (2022) -
Apolipoprotein M Serum Levels Correlate with IgA Vasculitis and IgA Vasculitis Nephritis
por: Wu, Jiali, et al.
Publicado: (2019)